Evidence map›Paper›PMID 27933547›Full record

ArticleNeurochemical research2017

Anti-Neuroinflammatory Effects of Fucoxanthin via Inhibition of Akt/NF-κB and MAPKs/AP-1 Pathways and Activation of PKA/CREB Pathway in Lipopolysaccharide-Activated BV-2 Microglial Cells.

Dong Zhao, Seung-Hwan Kwon, Yoon Sun Chun, Ming-Yao Gu, Hyun Ok Yang

Abstract read
PubMed Publisher
In one paragraph

Article in Neurochemical research, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 55 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
55citing papers in PubMed, 3 pooled it
4.0field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

55 citing papers in PubMed, 3 syntheses or guidelines pooled it, 111 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Non-Invasive Imaging for the Evaluation of a New Oral Supplement in Skin Aging: A Case-Controlled Study.Skin research and technology : official journal of International Society for Bioengineering and the Skin (ISBS) [and] International Society for Digital Imaging of Skin (ISDIS) [and] International Society for Skin Imaging (ISSI)
    Trial
  5. Review
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Review
  14. Glucagon-like peptide-1 receptor: mechanisms and advances in therapy.Signal transduction and targeted therapy · 2024 · on this map
    Review
  15. Antioxidants (Basel, Switzerland) · 2024
    Article
  16. Review
  17. Review
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Dong ZhaoNatural Product Research Center, KIST Gangneung Institute of Natural Products, Gangneung, 210-340, Republic of Korea.
Seung-Hwan KwonNatural Product Research Center, KIST Gangneung Institute of Natural Products, Gangneung, 210-340, Republic of Korea.
Yoon Sun ChunNatural Product Research Center, KIST Gangneung Institute of Natural Products, Gangneung, 210-340, Republic of Korea.
Ming-Yao GuNatural Product Research Center, KIST Gangneung Institute of Natural Products, Gangneung, 210-340, Republic of Korea.
Hyun Ok YangNatural Product Research Center, KIST Gangneung Institute of Natural Products, Gangneung, 210-340, Republic of Korea. hoyang@kist.re.kr.
Korea University of Science and Technology · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Microglia play a critical role in controlling the homeostasis of the brain, but over-activated microglia secrete pro-inflammatory mediators and cytokines, which induce neuronal cell death. Fucoxanthin (Fx), a marine carotenoid, has demonstrated a variety of beneficial health effects. Despite accumulating evidence supporting the immune-modulating effects of Fx in vitro, the underlying signaling pathways remain unknown. In the present study, Fx dose-dependently inhibited the secretion of lipopolysaccharide (LPS)-induced pro-inflammatory mediators including interleukin (IL)-6, tumor necrosis factor (TNF)-α, reactive oxygen species (ROS), prostaglandin (PG) E

Indexed as

AnimalsAnti-Inflammatory AgentsCell LineCell SurvivalCyclic AMP-Dependent Protein KinasesCyclic AMP Response Element-Binding ProteinDose-Response Relationship, DrugLipopolysaccharidesMAP Kinase Signaling SystemMiceMicrogliaNF-kappa BProto-Oncogene Proteins c-aktTranscription Factor AP-1XanthophyllsAnti-Inflammatory AgentsCreb1 protein, mouseCyclic AMP-Dependent Protein KinasesCyclic AMP Response Element-Binding ProteinfucoxanthinLipopolysaccharidesNF-kappa BProto-Oncogene Proteins c-aktTranscription Factor AP-1XanthophyllsBV-2 microgliaFucoxanthinNeuro-inflammationPKA/CREB pathway

Identifiers

PMID27933547
OpenAlexW2560341035

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.